Robert has over 35 years of experience in the biopharmaceutical industry with a specialty in Oncology. He has held roles as CEO of a Biotech as well as Sr Level positions in Major Pharma companies. Previously as the Executive Vice President and Head of the Oncology Strategic Business Unit at Bayer, Robert oversaw the Oncology franchise of Bayer AG globally. He also served on the Executive Committee for Bayer Pharmaceuticals. Before joining Bayer in 2015, Robert was the Senior Vice President and Head of Global Oncology at Bristol-Myers Squibb. Robert has experiences across multiple Therapeutic areas as well as different modalities including, Cell Therapies, Small Molecules & Biologics, Radiopharmaceuticals, Precision Oncology products with Diagnostics and IO compounds across a range of tumors including both Hem and Solid. He was also directly responsible for numerous multibillion dollar Oncology launches.

Robert serves on the Louisiana Tech College of Business Administration Advisory Board and is a member of AACR and BioCentury. He serves on the Board for Axiom REACH, a non-profit organization serving the needs of under-privileged cancer patients. He was also named one of New Jersey’s Top 25 Health Care Executives for 2022. Robert received a Bachelor of Science in Marketing from Louisiana Tech University.